dr. M.G.H. Betjes

Medicine & Life Sciences

1. Kidney Transplantation 100%
2. Tissue Donors 75%
3. Kidney 75%
4. Graft Survival 61%
5. Transplantation 60%
6. Immunosuppressive Agents 56%
7. Liver Transplantation 54%
8. Transplants 52%
9. Antibodies 45%
10. Medication Adherence 44%
11. T-Lymphocytes 43%
12. Allografts 42%
13. Tacrolimus 39%
14. rho Guanine Nucleotide Dissociation Inhibitor beta 39%
15. Mycophenolic Acid 35%
16. Transplant Recipients 33%
17. Alemtuzumab 32%
18. thymoglobulin 29%
19. Peripheral Tolerance 27%
20. Living Donors 26%
21. Immunoglobulin Domains 26%
22. Everolimus 25%
23. Angiotensin Type 1 Receptor 24%
24. T-Lymphocyte Epitopes 24%
25. Blood Group Antigens 24%
26. Uremia 23%
27. Extracellular Vesicles 23%
28. Helper-Inducer T-Lymphocytes 23%
29. Psychology Rejection 23%
30. Cytomegalovirus Infections 22%
31. Autoantibodies 18%
32. Transcriptome 18%
33. Immunosuppression 18%
34. Mesenchymal Stem Cells 18%
35. Fear 17%
36. Multicenter Studies 17%
37. Glomerular Filtration Rate 15%
38. Fibrosis 14%
39. Randomized Controlled Trials 14%
40. Pharmaceutical Preparations 14%
41. Elderly 14%
42. Genotype 14%
43. Natural Killer Cells 11%
44. Antibody Formation 11%
45. Infections 10%
46. Survival 8%
47. Therapeutics 8%
48. Fluorescence 8%
49. Weaning 8%
50. Transplantation Tolerance 7%